Medivation Agrees to Sell to Pfizer for $14 Billion

San Francisco – August 23, 2016 – Cooley is advising biopharmaceutical company Medivation on its agreement to sell to Pfizer for approximately $14 billion. The transaction is expected to close in the third or fourth quarter. Prior to the announced agreement, Cooley also advised Medivation as the target of a hostile takeover bid by Sanofi.

Medivation's portfolio includes XTANDI® (enzalutamide), an androgen receptor inhibitor that blocks multiple steps in the androgen receptor signaling pathway within the tumor cell. XTANDI is the leading novel hormone therapy in the US, generating approximately $2.2 billion in worldwide net sales over the past year. In addition, Medivation has a promising, wholly-owned, late-stage oncology pipeline, which includes two development-stage oncology assets.

Medivation has been a Cooley client since 2008.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.

Press Coverage

"Pfizer to Buy Cancer Drug Maker in $14 Billion Deal," The New York Times: DealBook

"Pfizer Boosts Cancer Drug Pipeline with $14 Billion Medivation Deal," Reuters

"Pfizer to Buy Cancer Drug Firm Medivation for $14 Billion," TIME

"Pfizer is Buying Cancer Drug Maker Medivation for $14 Billion," Fortune

"News Roundup," Bloomberg BNA

"Pfizer to Buy Medivation for $14 Billion in Cash," CNBC

"Medivation Scores Premium Price in Sale to Pfizer," The Deal

"R&D Impact May be Key in Scrutiny of Pfizer Oncology Deal," Law360

"Four Firms Guide Pfizer's Latest Big Drug Buy," The American Lawyer

"Cooley, Ropes and Wachtell Lead as Pfizer Recovers from Allergan Fall-Out," The Lawyer

"Pfizer Wins Over Medivation with $14B Buyout," Law360

"2 Law Firms Dominate M&A in Languid August," Law360

"Four Bidders Battled Pfizer for Medivation," The Deal

Related Contacts
Jamie Leigh Partner San Francisco
Kenneth Guernsey Partner San Francisco, Palo Alto
Barbara Kosacz Senior Counsel Palo Alto
Marty Schenker Partner San Francisco
Patrick Gibbs Partner Palo Alto
Jacqueline Grise Partner Washington, DC
Barbara Mirza Partner Los Angeles, Palo Alto
Thomas Welk Senior Counsel San Diego
Natasha Leskovsek Of Counsel Washington, DC
Brett White Of Counsel Palo Alto
Susan Cooper Philpot Retired Partner San Francisco
Sarah Lightdale Partner New York
Cydney Posner Special Counsel San Francisco
Ben Beerle Partner San Francisco
Anne Lieberman Partner Los Angeles
Tanisha A. James Partner New York, Washington, DC